--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
SPORTS
LIFE
PEOPLE
TRAVEL
WEEKLY REVIEW
Film in China
War on Poverty
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates
Hotel Service
China Calendar
Telephone and
Postal Codes


Hot Links
China Development Gateway
Chinese Embassies

Medicine in Clinical Tests

A traditional Chinese medicine developed by local doctors to treat fatty liver is expected to be the first Chinese herb to go through proper clinical testing and be industrialized by the National Food and Drug Administration next year.

Dr Liu Zhihua from Shanghai's Punan Hospital has been involved in the study of hepatitis B, fatty liver and cirrhosis more than 30 years. He created the drug, danshaogankang, in the late 1990s and received a patent for the product in 2000.

"The medicine is a completely Chinese herb, and we will use testing methods and experiments from Western countries to test its effects. It also took years for the authorities to give me a patent," said Liu.

"To ensure its effects and safety, I spent over one year on animal tests and then applied to conduct clinical tests. Currently, the FDA has approved us to do test in five designated hospitals in Beijing, Shanghai and Nanjing."

More than 90 percent of the subjects involved in current testing have shown positive reactions to the drug, he said.

After danshaogankang is industrialized, Liu said he will turn his focus to another TCM he has developed to treat cirrhosis.

(Shanghai Daily May 30, 2005)

Traditional Chinese Medicine: a Magnetic to Foreign Students
Traditional Chinese Medicine to Apply for World Heritage
Obesity Weighs Down Shanghai's Children
60% Adult Beijingers Are Overweight
Print This Page
|
Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688